Kirstin A. van der Keur

Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome

Yves Allory, Willemien Beukers, Ana Sagrera et al. · European Urology · 2013 · 289 citations · Full text

Medicine, Genetics, Oncology +16

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer

Emil Christensen, Karin Birkenkamp‐Demtröder, Iver Nordentoft et al. · European Urology · 2017 · 197 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

Kim E.M. van Kessel, Willemien Beukers, Irene Lurkin et al. · The Journal of Urology · 2016 · 154 citations

Medicine, Oncology, Urology +17

Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])

Madelon N.M. van der Aa, Ellen C. Zwarthoff, Ewout W. Steyerberg et al. · European Urology · 2008 · 96 citations

Medicine, Oncology, Urology +15

<i>FGFR3</i> , <i>TERT</i> and <i>OTX1</i> as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study

Willemien Beukers, Kirstin A. van der Keur, Raju Kandimalla et al. · The Journal of Urology · 2017 · 92 citations

Medicine, Oncology, Urology +15